Yahoo! Finance Search - Finance Home - Yahoo! - Help

Wednesday, September 17 2014 9:41am ET - U.S. Markets close in 6 hours and 19 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Major News
Latest News
Wednesday, Sep 17, 2014
·Merck Presents First Phase 3 Data in Japanese Patients for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes
Business Wire - 10 minutes ago
·Impax Pharmaceuticals Announces Extension of RYTARY™ FDA Review Date to January 9, 2015
PR Newswire - 41 minutes ago
·Tetraphase (TTPH) is in Overbought Territory: What's Next? - 58 minutes ago
·Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease
PR Newswire - 1 hour, 7 minutes ago
·Sun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab
Business Wire - 1 hour, 11 minutes ago
·Sanofi Wants to Add Oral GLP-1 to Diabetes Offer, Chancel Says
at Bloomberg - Wed 2:58 am ET
Tuesday, Sep 16, 2014
·Final Glance: Pharmaceuticals companies
AP - Tue 7:46 pm ET
·NanoViricides Reports That Its CEO Dr. Seymour Will Be Interviewed about the Evolving Ebola Crisis on Fox Business News at 9PM EDT This Evening
Business Wire - Tue 7:33 pm ET
·Urine test for cervical cancer virus offers alternative to smear
Reuters - Tue 6:30 pm ET
·Retrophin Announces Changes to Board of Directors and Management Team
Business Wire - Tue 5:00 pm ET
·Bristol-Myers Squibb Announces Dividend
Business Wire - Tue 4:30 pm ET
·AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug - Tue 4:20 pm ET
·AbbVie Sued by Pension Fund Over $54.5 Billion Shire Deal
at Bloomberg - Tue 3:46 pm ET
·Nektar says FDA clears constipation drug Movantik
AP - Tue 2:02 pm ET
·Dow Jones (DJIA) Today: Merck (MRK) Higher
at - Tue 2:00 pm ET
·FDA Approves MOVANTIK™ (naloxegol) Tablets C-II for the Treatment of Opioid-Induced Constipation in Adult Patients with Chronic Non-Cancer Pain
Business Wire - Tue 1:58 pm ET
·Gilead Up As Analyst Lifts Sovaldi Q3 Estimate
at Investor's Business Daily, Inc. - Tue 1:57 pm ET
·Midday Glance: Pharmaceuticals companies
AP - Tue 1:22 pm ET
·How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
at - Tue 12:36 pm ET
·Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine
PR Newswire - Tue 12:33 pm ET
More Latest News...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
Accelerated Study Start
Clinical trial site identification, feasibility, and activation.
Health Care Consulting
Go To To Find Local Businesses And Services Near You!
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?